RAC 2.73% $1.61 race oncology ltd

I agree with you and I've liked your post; it's not...

  1. 2,765 Posts.
    lightbulb Created with Sketch. 2448
    I agree with you and I've liked your post; it's not going to ATH until the market gets readouts.

    OTOH we have results like:
    Sheba II where the results are out: it works and the cardiotoxic drug isn't cardiotoxic in combo with bisantrene;
    50 trials where it ultimately got approved;
    Preclinicals that are in valid reliable models that show CPACS;
    Preclinicals that aren't released, that I believe have to be released if they're bad news.

    I like the finish line analogy from the latest DrT interview; it's as though if you do enough research here, then you know or can be pretty certain of the readouts before the readouts come. It's still a gamble but I like those odds!
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.